Case Report: Pembrolizumab–induced myasthenia gravis with isolated anti-titin antibody positivity after thymectomy for thymoma
BackgroundImmune checkpoint inhibitors (ICIs), including pembrolizumab, are increasingly used in cancer treatment but can cause immune-related adverse events such as myasthenia gravis (MG). We report a case of pembrolizumab-induced myasthenia gravis characterized by isolated anti-titin antibody posi...
Na minha lista:
| Principais autores: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2026-09-01
|
| Serier: | Frontiers in Drug Discovery |
| Fag: | |
| Online adgang: | https://www.frontiersin.org/articles/10.3389/fddsv.2026.1932554/full |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
